Expertise:   

Synthetic organic chemistry, medicinal chemistry; API manufacture including process scaleup, optimization and troubleshooting, and commercial implementation; halogenated ether inhalation anesthetic manufacture, purification, packaging and delivery, including related medical devices; small molecule preclinical and early clinical development and CMC; manufacturing anomaly root cause investigation; peptide synthesis and purification.

Experience:  

 Baxter Principal Scientist and Head of Baxter Anesthesia Science R&D; Baxter technical lead for human recombinant hyaluronidase development partnership with Halozyme Therapeutics; leadership and program management of multiple NCE development programs for GI and Oncology drugs; experience in patent litigation activities; global regulatory affairs.

Other:  

Member, American Chemical Society; volunteer expert on USP panel.